JANUVIA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Sitagliptin Phosphate.
| Product ID | 0006-0277_18128ec1-8748-4f68-a7e8-f004ec697b29 |
| NDC | 0006-0277 |
| Product Type | Human Prescription Drug |
| Proprietary Name | JANUVIA |
| Generic Name | Sitagliptin |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2006-10-16 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021995 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | SITAGLIPTIN PHOSPHATE |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2006-10-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021995 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-10-16 |
| Marketing End Date | 2012-03-09 |
| Marketing Category | NDA |
| Application Number | NDA021995 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-10-16 |
| Marketing Category | NDA |
| Application Number | NDA021995 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-10-12 |
| Marketing Category | NDA |
| Application Number | NDA021995 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-10-16 |
| Marketing End Date | 2015-09-30 |
| Marketing Category | NDA |
| Application Number | NDA021995 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-10-16 |
| Marketing Category | NDA |
| Application Number | NDA021995 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-10-16 |
| Marketing Category | NDA |
| Application Number | NDA021995 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-10-16 |
| Marketing Category | NDA |
| Application Number | NDA021995 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-10-16 |
| Marketing End Date | 2016-02-29 |
| Marketing Category | NDA |
| Application Number | NDA021995 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-10-16 |
| Marketing Category | NDA |
| Application Number | NDA021995 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-10-16 |
| Marketing Category | NDA |
| Application Number | NDA021995 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-10-16 |
| Ingredient | Strength |
|---|---|
| SITAGLIPTIN PHOSPHATE | 100 mg/1 |
| SPL SET ID: | f85a48d0-0407-4c50-b0fa-7673a160bf01 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0006-0112 | JANUVIA | sitagliptin |
| 0006-0221 | JANUVIA | sitagliptin |
| 0006-0277 | JANUVIA | sitagliptin |
| 50090-3472 | JANUVIA | sitagliptin |
| 50090-3527 | JANUVIA | sitagliptin |
| 50090-4084 | JANUVIA | sitagliptin |
| 50090-4086 | JANUVIA | sitagliptin |
| 50090-4087 | JANUVIA | sitagliptin |
| 50090-5517 | JANUVIA | sitagliptin |
| 50090-5547 | JANUVIA | sitagliptin |
| 50090-5585 | JANUVIA | sitagliptin |
| 55154-5040 | JANUVIA | sitagliptin |
| 55154-5042 | JANUVIA | sitagliptin |
| 55154-5044 | JANUVIA | JANUVIA |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() JANUVIA 78833412 3621009 Live/Registered |
MERCK SHARP & DOHME CORP. 2006-03-09 |
![]() JANUVIA 76635570 3261637 Live/Registered |
MERCK SHARP & DOHME CORP. 2005-04-07 |